STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision.  The Company manufactures implantable contact lenses to treat refractive disorders such as myopia.  STAAR also manufactures products for cataract surgery and glaucoma surgery.

Current Report (Amendment) (Form 8-K/A | Period ending 2024-10-30)

Quarterly Report (Form 10-Q | Period ending 2024-09-27)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Staar Surgical Co (STAA US)

Current Report (Amendment) (Form 8-K/A | Period ending 2024-10-30)

Quarterly Report (Form 10-Q | Period ending 2024-09-27)

Current Report (Form 8-K | Period ending 2024-10-30)

Quarterly Report (Form 10-Q | Period ending 2024-06-28)

Current Report (Form 8-K | Period ending 2024-08-07)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)